Progression of m 6 A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Xuan Han,Yu Zhu,Juan Ke,Yufeng Zhai,Min Huang,Xin Zhang,Hongjie He,Xiaojing Zhang,Xuehong Zhao,Kaikai Guo,Xianglin Li,Zhongyu Han,Yanming Zhang
DOI: https://doi.org/10.1038/s41420-024-02092-2
2024-07-20
Cell Death Discovery
Abstract:Recently, N6-methyladenosine (m 6 A) has aroused widespread discussion in the scientific community as a mode of RNA modification. m 6 A comprises writers, erasers, and readers, which regulates RNA production, nuclear export, and translation and is very important for human health. A large number of studies have found that the regulation of m 6 A is closely related to the occurrence and invasion of tumors, while the homeostasis and function of the tumor microenvironment (TME) determine the occurrence and development of tumors to some extent. TME is composed of a variety of immune cells (T cells, B cells, etc.) and nonimmune cells (tumor-associated mesenchymal stem cells (TA-MSCs), cancer-associated fibroblasts (CAFs), etc.). Current studies suggest that m 6 A is involved in regulating the function of various cells in the TME, thereby affecting tumor progression. In this manuscript, we present the composition of m 6 A and TME, the relationship between m 6 A methylation and characteristic changes in TME, the role of m 6 A methylation in TME, and potential therapeutic strategies to provide new perspectives for better treatment of tumors in clinical work.
cell biology